How many insider trades does FilingIQ track for PCRX?

FilingIQ tracks 805 Form 4 insider transactions for PCRX (Pacira Pharmaceuticals, Inc.), covering filings from Jan 12, 2015 onwards. 14 of those were filed in the last 90 days.

Are PCRX insiders net buyers or net sellers?

Across the full Form 4 history for PCRX, 19 transactions (2%) were open-market purchases and 333 (41%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does PCRX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is PCRX in?

Pacira Pharmaceuticals, Inc. (PCRX) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $1.09B.

PCRX insider trading

NasdaqGS Healthcare

Pacira Pharmaceuticals, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

805

Last 90 days

Buys / sells

2% / 41%

Market cap

$1.09B

About Pacira Pharmaceuticals, Inc.

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Company website: www.pacira.com

PCRX insider activity at a glance

FilingIQ has scored 805 insider transactions for PCRX since Jan 12, 2015. The most recent filing in our index is dated Apr 23, 2026.

Across the full history, 19 open-market purchases and 333 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on PCRX insider trades is 57.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live PCRX trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for PCRX?: FilingIQ tracks 805 Form 4 insider transactions for PCRX (Pacira Pharmaceuticals, Inc.), covering filings from Jan 12, 2015 onwards. 14 of those were filed in the last 90 days.
Are PCRX insiders net buyers or net sellers?: Across the full Form 4 history for PCRX, 19 transactions (2%) were open-market purchases and 333 (41%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does PCRX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is PCRX in?: Pacira Pharmaceuticals, Inc. (PCRX) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $1.09B.

Methodology & sources

Every PCRX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.